Subject
Computational Mathematics,Modeling and Simulation
Reference38 articles.
1. J. Svensson, J. Mölne, E. Forssell-Aronsson, M. Konijnenberg, and P. Bernhardt, “Nephrotoxicity profiles and threshold dose values for [177Lu] – DOTATATE in nude mice,” Nucl. Med. Biol. 39 (6), 756–762 (2012). https://doi.org/10.1016/j.nucmedbio.2012.02.003
2. B. Lambert, M. Cybulla, S. M. Weiner, C. Van De Wiele, H. Ham, R. A. Dierckx, et al., “Renal toxicity after radionuclide therapy,” Radiat. Res. 161 (5), 607–611 (2004). https://doi.org/10.1667/rr3105
3. E. Vegt, M. De Jong, J. F. M. Wetzels, R. Masereeuw, M. Melis, W. J. Oyen et al., “Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention,” J. Nucl. Med. 51 (7), 1049–1058 (2010). https://doi.org/10.2967/jnumed.110.075101
4. A. A. Flynn, R. B. Pedley, A. J. Green, J. L. Dearling, E. El-Emir, GM. Boxer et al., “The nonuniformity of antibody distribution in the kidney and its influence on dosimetry,” Rad. Res. 159 (2), 182–189 (2003). https://doi.org/10.1667/0033-7587(2003)159[0182:tnoadi]2.0.co;2
5. M. Konijnenberg, M. Melis, R. Valkema, E. Krenning, and M. De Jong, “Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy,” J. Nucl. Med. 48 (1), 134–142 (2007).